CIK 0001875558
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nuvectis Pharma, Inc.
Sign in to watch- Ticker
- NVCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 862405608
- Phone
- +1 360-837-7232
- Business address
- 1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Kaplan Matthew L. Director | Grant or award | +35,000 | 159,760 | ||
| 2025-11-05 | Kaplan Matthew L. Director | Purchase | +11,000 | $5.84 | $64K | 124,760 |
| 2025-06-12 | Kaplan Matthew L. Director | Grant or award | +30,000 | 113,760 | ||
| 2024-06-13 | Kaplan Matthew L. Director | Grant or award | +30,000 | 83,760 | ||
| 2023-06-16 | Kaplan Matthew L. Director | Grant or award | +18,000 | 53,760 | ||
| 2022-05-12 | Kaplan Matthew L. Director | Purchase | +1,177 | $15.96 | $19K | 33,937 |
| 2022-05-12 | Kaplan Matthew L. Director | Purchase | +1,823 | $17.47 | $32K | 35,760 |
| 2022-04-01 | Kaplan Matthew L. Director | Grant or award · Stock Options (right to buy) | +15,000 | 15,000 |
Page 1 of 1 · 8 trades